These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6806545)

  • 21. Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations.
    Perrault LP; Menasché P; Wassef M; Bidouard JP; Janiak P; Villeneuve N; Jacquemin C; Bloch G; Vilaine JP; Vanhoutte PM
    Ann Thorac Surg; 1996 Oct; 62(4):1158-63. PubMed ID: 8823106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to avoid severe coronary vasoconstriction in potassium induced cardioplegia.
    Qin G; Chen L; Sjöberg T; Steen S
    Scand Cardiovasc J; 2018 Dec; 52(6):344-347. PubMed ID: 30486695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacidipine decreases the honeybee venom-induced vasoconstriction of the isolated porcine coronary artery.
    Cerne K; Drevensek G; Budihna MV
    Pflugers Arch; 2000; 440(5 Suppl):R139-40. PubMed ID: 11005644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study on the effects of compositions of cardioplegic solutions on coronary arteries].
    Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S; Kusagawa M; Hidaka H
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Mar; 32(3):294-300. PubMed ID: 6747363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-ischemic protection of the myocardium by cardioplegic solutions].
    Onishchenko NA; Lubiako AA
    Vestn Akad Med Nauk SSSR; 1985; (4):40-7. PubMed ID: 4013508
    [No Abstract]   [Full Text] [Related]  

  • 26. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cocaine on the coronary arteries.
    Benzaquen BS; Cohen V; Eisenberg MJ
    Am Heart J; 2001 Sep; 142(3):402-10. PubMed ID: 11526352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Composition of cardioplegic solutions used in nine medical centers.
    Klamerus KJ; Munger MA
    Am J Hosp Pharm; 1986 Jun; 43(6):1479-82. PubMed ID: 3487977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved myocardial preservation by improved distribution of cardioplegic solutions.
    Vander Salm TJ; Okike ON; Cutler BS; Paraskos JA; Ferulo J; Daggett W
    J Thorac Cardiovasc Surg; 1982 May; 83(5):767-71. PubMed ID: 7078245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium entry blockers and cardioplegia: interaction between nifedipine, potassium, and hypothermia.
    Chiavarelli M; Chiavarelli R; Macchiarelli A; Carpi A; Marino B
    Ann Thorac Surg; 1986 May; 41(5):535-41. PubMed ID: 3707247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immediate effects of desoxycorticosterone of vasomotor properties of noradrenaline and isoprenaline in rats].
    Dejalle J; Cession-Fossion A; Lecomte J
    C R Seances Soc Biol Fil; 1978; 172(5):1009-12. PubMed ID: 157187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cardioplegic solutions and their components on human saphenous vein contractility.
    Chiavarelli M; Fabi F; Stati T; Chiavarelli R; del Basso P
    Ann Thorac Surg; 1992 Mar; 53(3):455-9. PubMed ID: 1540064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial protection.
    Lolley DM; Ray JF; Meyers WO; Sautter RD
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):631-3. PubMed ID: 423599
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasoconstriction induced by soluble factors derived from human placenta.
    Vadillo F; Hong E; De León H; Bustos HH; Contreras J; Castañeda-Hernández G; Karchmer S
    Proc West Pharmacol Soc; 1991; 34():183-7. PubMed ID: 1788280
    [No Abstract]   [Full Text] [Related]  

  • 36. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease.
    Turlapaty PD; Altura BM
    Science; 1980 Apr; 208(4440):198-200. PubMed ID: 7361117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Continuous measurement of potassium and sodium losses of the myocardium during a heart arrest by coronary perfusion with low sodium, calcium-free, procaine containing, oxygen saturated cardioplegic solutions].
    Orellano LE; Grebe D; Bretschneider HJ
    Arch Kreislaufforsch; 1967 Aug; 53(3):264-307. PubMed ID: 5596369
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study in vitro of the mechanical responses of segments of coronary arteries and of hepatic artery to changes of the ionic composition of the medium].
    Midrio M; Bettini V
    Arch Sci Biol (Bologna); 1968; 52(3):183-208. PubMed ID: 4973683
    [No Abstract]   [Full Text] [Related]  

  • 39. Sinus slowing produced by intracoronary arterial injections of hyperosmotic solutions in man.
    Abe S; Itoh M; Unakami H; Kobayashi T
    Am Heart J; 1976 Mar; 91(3):339-45. PubMed ID: 1258732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of potassium chloride and magnesium chloride on electrocardiographic and morphological changes in ischemic necrosis of the myocardium].
    Shustval' NF; Berestov AA
    Patol Fiziol Eksp Ter; 1973; 17(6):19-23. PubMed ID: 4779620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.